Showing results (1381-1390 of 6,159) with videos related to
Sort By:
Pageof 616
Nature Medicine|January 14, 2026
Circulating metabolites, genetics and lifestyle factors in relation to future risk of type 2 diabetesJun Li, Jie Hu, Huan Yun, et al.Nature Medicine|January 7, 2026
Soluble MAdCAM-1 as a biomarker in metastatic renal cell carcinomaCarolina Alves Costa Silva, Marc Machaalani, Renee Maria Saliby, et al.Nature Medicine|January 6, 2026
Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990-2023: a Global Burden of Disease studyJiyeon Oh, Soeun Kim, Yesol Yim, et al.Nature Medicine|January 15, 2026
Genotype-stratified adjunctive dexamethasone for tuberculous meningitis in HIV-negative adults: a randomized controlled phase 3 trialJoseph Donovan, Nguyen Duc Bang, Huu Khanh Trinh Dong, et al.Nature Medicine|January 28, 2026
Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trialSreya Duttagupta, Meriem Messaoudene, Sebastian Hunter, et al.Nature Medicine|February 3, 2026
Scaling medical AI across clinical contextsMichelle M Li, Ben Y Reis, Adam Rodman, et al.Nature Medicine|February 6, 2026
A large language model for complex cardiology careJack W O'Sullivan, Anil Palepu, Khaled Saab, et al.Nature Medicine|December 8, 2025
Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trialJennifer M Kwon, Francina Munell, Laure Le Goff, et al.Nature Medicine|December 1, 2025
Liraglutide in mild to moderate Alzheimer's disease: a phase 2b clinical trialPaul Edison, Grazia Daniela Femminella, Craig Ritchie, et al.Nature Medicine|January 8, 2025
Neoadjuvant anti-PD-1 alone or in combination with anti-TIGIT or an oncolytic virus in resectable stage IIIB-D melanoma: a phase 1/2 trialReinhard Dummer, Caroline Robert, Richard A Scolyer, et al.Pageof 616